Clinical Microbiology Reviews

Papers
(The median citation count of Clinical Microbiology Reviews is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Extracutaneous sporotrichosis352
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections197
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility175
Transmission of Infections during Cardiopulmonary Resuscitation155
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders125
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance120
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease109
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”107
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus106
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves102
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant100
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities99
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases94
Viral infections and pathogenesis of glaucoma: a comprehensive review88
Progression of antibiotic resistance in Neisseria meningitidis83
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options78
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics75
Evolutionary Pathways and Trajectories in Antibiotic Resistance74
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance70
Review of BCG immunotherapy for bladder cancer69
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms65
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control65
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory65
Neisseria gonorrhoeae vaccines: a contemporary overview61
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen60
Congenital Syphilis: a Review of Global Epidemiology58
Bacterial and fungal infections in persons who inject drugs57
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature57
Diagnosis, Management, and Future Control of Cholera56
BCG therapy in bladder cancer and its tumor microenvironment interactions55
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease55
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections54
Aspergillus terreus Species Complex52
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes52
Rapid and accurate testing for urinary tract infection: new clothes for the emperor49
Trained Immunity as a Preventive Measure for Surgical Site Infections49
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome48
Harnessing the host response for precision infectious disease diagnosis46
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)45
Artemisinin-resistant malaria45
Agnostic Sequencing for Detection of Viral Pathogens44
Editorial Board43
2021 Acknowledgment of CMR Reviewers43
The challenges of difficult-to-treat Acinetobacter infections42
Pathogenesis of viral infections during pregnancy42
COVID-19 therapeutics38
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing36
Pneumocystis jirovecii pneumonia in people living with HIV: a review36
Human toxocariasis35
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response35
SARS-CoV-2 Antiviral Therapy34
Editorial Board32
Editorial Board31
Natural-Product-Based Solutions for Tropical Infectious Diseases31
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease30
Updated Review onNocardiaSpecies: 2006–202130
Invasive fusariosis30
Osteoarticular Mycoses29
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence28
Clinical Microbiology Reviews : a 21st century vision24
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management23
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective23
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis23
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream22
Host Immunity and Immunization Strategies for Clostridioides difficile Infection22
Skin microbiota in atopic dermatitis: victim or executioner?22
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities20
Masks and respirators for prevention of respiratory infections: a state of the science review19
Prion Dissemination through the Environment and Medical Practices: Facts and Risks for Human Health18
Current perspectives in the epidemiology and control of lymphatic filariasis18
Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era18
Surveillance and prevention of infection in clinical xenotransplantation18
The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis18
Advancements and challenges in antifungal therapeutic development18
A call for the United States to continue investing in science17
Correction for Moreland et al., “Rapid and accurate testing for urinary tract infection: new clothes for the emperor”17
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections17
Human Listeriosis16
2023 Acknowledgment of CMR Reviewers16
Neurological complications caused by SARS-CoV-215
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis15
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies13
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells13
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials13
Adoptive T-cell therapy for virus-associated diseases12
2024 Acknowledgment of CMR Reviewers12
Monkeypox Virus Infections in Humans11
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection11
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management10
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations10
Practical Guidance for Clinical Microbiology Laboratories: Microbiologic diagnosis of implant-associated infections10
The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review10
0.029340982437134